
Medigene licences CD40L-CD28 costimulatory switch receptor
Medigene has licences the global exclusive rights for CD40L-CD28 costimulatory switch receptor from the Helmholtz Centre Munich. Financial details...

Sanofi's/Astazeneca's anti-RSV antibody highly effective
Reduced immunity in the wake of the COVID-19 pandemic has contributed to large surges in respiratory syncytial virus (RSV) infections. After...

Oculis lists at Nasdaq through SPAC merger
Upon closing of the $104m SPAC deal with European Biotech Acquisition Corp, Oculis had a pro-forma enterprise value of approximately $220m and a cash...

5 Alarm Bio Ltd raises £500K in seed round
Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, as well as other angel investors participated in Five Alarm Bio’s (FAB) seed round with...

FAO presents food safety assessment on cell-based protein products
With more than 100 companies, including Israel's Aleph Farms, Holland's Mosa Meat and the UK's Higher Steaks Ltd., active in the future market of...

Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals
According to the agreement, Secarna Pharmaceuticals GmbH & Co KG (Planegg, Germany) will identify and validate antisense locked nucleic acid...

Vitestro raises €12m in Series A financing
California-based Sonder Capital led the Series A financing round alongside existing investors and new private investors. According to...